|
|
 |
|
Viewing report
|
|
|
|
Lotus Pharmaceuticals, Inc. (LTUS) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 36
Lotus Pharmaceuticals, Inc. (LTUS) - Financial and Strategic SWOT Analysis Review
Summary
Lotus Pharmaceuticals, Inc. (Lotus) is engaged in the development, manufacture and distribution of prescription drugs and pharmaceutical products. It operates and has ownership interests in Liang Fang Pharmaceutical, Ltd. (Liang) and En Zhe Jia Shi Pharmaceutical, Ltd. (En Zhe). Liang and En Zhe are collectively refereed as Lotus East and are together engaged in the production, trade, sales and marketing of pharmaceuticals. In China, both companies possess some of the most advanced pharmaceutical-production equipment. The company owns and operates 10 drug stores in Beijing, China, engaged in the sale of western and traditional Chinese medications, lease medical treatment facilities. Its current drug development pipeline has major focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The company is headquartered in Beijing, China.
Lotus Pharmaceuticals, Inc. Key Recent Developments
Aug 15, 2011: Lotus Pharmaceuticals Reports Total Revenue Of $18.7m In Q2 2011
May 16, 2011: Lotus Pharmaceuticals Reports Net Income Of $2.2m For Q1 2011
Mar 28, 2011: Lotus Reports Net Income Of $14.4m For 2010
Feb 04, 2011: Lotus To Expand Construction Of Beijing Facility
Dec 21, 2010: Lotus Pharmaceuticals Announces Board Changes
This comprehensive SWOT profile of Lotus Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review
SciClone Pharmaceuticals, Inc. (SCLN) - Financial and Strategic SWOT Analysis Review
Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
WEX Pharmaceuticals Inc. (WXI) - Financial and Strategic SWOT Analysis Review
China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review
Amylin Pharmaceuticals, Inc. (AMLN) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
West Pharmaceutical Services, Inc. (WST) - Financial and Strategic SWOT Analysis Review
|
|
|
|
